Moonlight Bio

Moonlight Bio is a company dedicated to the research and development of cell therapies for cancer treatment. Its operations cover exploratory research, component design and screening, preclinical modeling, process and analytical development, as well as translational and clinical research, aiming to develop treatments and drugs that help improve patients' quality of life. The company focuses on innovative T-cell therapy R&D, striving to create more effective treatment options for cancer patients. By harnessing the adaptive capabilities of T-cells evolved through human biology, Moonlight Bio enhances T-cell proliferation, longevity, and immune function to develop potent enhanced T-cell therapies, with a particular focus on tackling difficult-to-treat cancers such as solid tumors. The company's core mission is to leverage evolutionary mechanisms to unlock breakthrough advancements in T-cell efficacy, delivering highly effective T-cell therapeutic products for cancer patients. The team concentrates on innovative technology R&D, spanning the entire chain from discovery research, target screening, preclinical models, process and analytical development, translational research, to collaborative development.